BEVACIPTIN bevacizumab 400 mg/16 mL concentrated solution for infusion vial Cancelled under Section 30(1)(c) of the Act
Product name
BEVACIPTIN bevacizumab 400 mg/16 mL concentrated solution for infusion vial
Sponsor
ARTG details
- 347293
Date of effect
Decision type
Cancelled under Section 30(1)(c) of the Act